NRx Pharmaceuticals (NRXP)
(Delayed Data from NSDQ)
$2.52 USD
+0.06 (2.44%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $2.55 +0.03 (1.19%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
NRXP 2.52 +0.06(2.44%)
Will NRXP be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NRXP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NRXP
Here's Why NRx Pharmaceuticals (NRXP) Is a Great 'Buy the Bottom' Stock Now
NRx Pharmaceuticals to Post Q4 Earnings: How to Play the Stock?
NRXP: What are Zacks experts saying now?
Zacks Private Portfolio Services
Best Momentum Stocks to Buy for January 6th
New Strong Buy Stocks for January 6th
Best Momentum Stocks to Buy for December 30th
Other News for NRXP
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. ...
HOPE Therapeutics, NRx Pharmaceuticals cleared to close Dura Medical acquisition
NRXP: Analyst Jason Kolbert Maintains 'Buy' Rating at $31.00 | NRXP Stock News
NRx Pharmaceuticals (NRXP) Seeks FDA Action on Ketamine Preservative
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of a Citizen Petition with the US Food ...